Influenza cost and cost-effectiveness studies globally - A review

Vaccine

Volumn 31, Issue 46, 2013, Pages 5339-5348

  Peasah, Samuel K ^a   Azziz Baumgartner, Eduardo ^a   Breese, Joseph ^a   Meltzer, Martin I ^a   Widdowson, Marc Alain ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Cost effectiveness analysis; Global; Influenza; Vaccination

Indexed keywords

COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE POLICY; HOSPITALIZATION; HUMAN; INCOME; INFLUENZA; INFLUENZA VACCINATION; LOWEST INCOME GROUP; META ANALYSIS; PANDEMIC INFLUENZA; PRIORITY JOURNAL; REVIEW; SEASONAL INFLUENZA; SYSTEMATIC REVIEW;

COST EFFECTIVENESS ANALYSIS; GLOBAL; INFLUENZA; VACCINATION;

COST-BENEFIT ANALYSIS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; VACCINATION; WORLD HEALTH;

EID: 84886094289     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.09.013     Document Type: Review

References (25)

1. WHO. Influenza fact sheet. Available from:. http://www.who.int/mediacentre/factsheets/2003/fs211/en.
2. Radin J.M., Katz M.A., Tempa S., Talla-Nzussouo N., Davis R., Duque J., et al. Influenza surveillance in 15 countries in Africa, 2006-2010. J Infect Dis 2012, 206(December (Suppl.)):S14-S21.
3. Dawood F.S., Iuliano A.D., Reed C., Meltzer M.I., Shay D.K., Cheng P.Y., et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus. Lancet Infect Dis 2012, 12(September (9)):687-695.
4. Cohen C., Simonsen L., Kang J.W., Miller M., Madhi S.A., Campsmith M., et al. Elevated influenza-related excess mortality in South Africa elderly individuals 1998-2005. Clin Infect Dis 2010, 51:1362-1369.
5. Report of the second WHO consultation on the Global Action Plan for influenza vaccines (GAP) Geneva, Switzerland, 12-14 July 2011.
6. Partridge J., Kieny M.P. Global production capacity of seasonal influenza vaccine in 2011. Vaccine 2013, 31(January (5)):728-731.
7. Robero-Alvarez A.M., Kurtis H.J., Danovaro-Holliday M.C., Ruiz-Matus C., Andrus J.K. Expansion of seasonal influenza vaccination in the Americas. BMC Public Health 2009, 9:361.
8. Plianbangchang, Samlee (Regional Director, WHO South-East-Asia). Vaccine development in the developing world; past, present and future: SEAR perspective 2010. Available from:. http://www.searo.who.int/LinkFiles/RD-speech15june2010.pdf.
9. World Bank Gross National Income figures across countries. Available from:. http://data.worldbank.org/indicator/NY.GNP.PCAP.CD.
10. Prevention and control of influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)-United States, 2012-13 influenza season. Available from:. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6132a3.htm.
11. Organization for Economic Co-operation and Development. Purchasing Power Parities. Available from: [accessed 14.11.11]. http://stats.oecd.org/index.aspx.
12. US Bureau of Labor and Statistics. Consumer price indexes. Washington, DC. Available from:. http://www.bls.gov/cpi.
13. Influenza Outbreak-Madagascar; July-August 2002. CDC MMWR weekly 2002;51(November (45)):1016-8. Available from:. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5145a2.htm.
14. Fitzner K.A., Shortridge K.F., McGhee S.M., Hedley A.J. Cost-effectiveness study on influenza prevention in Hong Kong. Health Policy 2001, 56:215-234.
15. Office of Technology Assessment Report on cost of flu.pdf. Cost effectiveness of influenza vaccination. Washington, December 1981.
16. Molinari N.M., Ortega-Sanchez I.R., Messonnier M.L., Thompson W.W., Wortley P.M., Weintraub E., et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007, 25:5086-5096.
17. Szucs T.D. Influenza The role of burden-of-illness research. Pharmacoeconomics 1999, 16(Suppl. 1):27-32.
18. Szucs T.D., Behrens M., Volmer T. Public health costs of influenza in Germany 1996-a-cost-of-illness analysis. Med Klin (Munich) 2001, 96(February (2)):63-70.
19. Health care systems-Four basic models. Available from:. http://www.pnhp.org/single_payer_resources/health_care_systems_four_basic_models.php.
20. Newall A.T., Scuffham P.A. Influenza-related disease: the cost to the Australian healthcare system. Vaccine 2008, 26:6818-6823.
21. Xue Y., Kristiansen I.S., De Blasio B.F. Modeling the cost of influenza: the impact of missing costs of unreported complications and sick leave. BMC Public Health 2010, 10:724.
22. Levy E. French economic evaluations of influenza and influenza vaccination. Pharmacoeconomics 1996, 9(Suppl. 3):26-33.
23. Badia Llach X., Roset Gamisans M., Frances Tudel J.M., Alvarez Sans C., Rubio Terres C. Study of flu costs. Aten Primaria 2006, 38(September (5)):260-267.
24. Hara Y., Ikematu H., Nabeshima A., Hagihara A., Nobutomo K., Kashiwagi S., et al. Cost of medication for influenza infected elderly inpatients. Kansenshogaku Zasshi 1999, 73(July (7)):689-693.
25. Simmerman J.M., Lertiendumrong J., Dowell S.F., Uyeki T., Olsen S.J., Chittagenpitch M., et al. The cost of influenza in Thailand. Vaccine 2006, 24:4417-4426.